Krebsmedikamente

Starkes Medizintechnikgeschäft führt zu Gewinnwachstum bei Johnson & Johnson (J&J)

Johnson & Johnson's stock takes a hit as profit forecast narrows: The company reports a billion-dollar profit in Q1 despite reduced expectations for the year ahead. Follow the latest updates here. #JandJ #StockMarket #Finance #Profit #Investing